Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MUC-1 CD40L dendritic cell vaccine - MicroVAX

Next Previous
Search
Drug Profile

MUC-1 CD40L dendritic cell vaccine - MicroVAX

Alternative Names: Ad-sig-hMUC-1/ecdCD40L; CD40L MUC-1 dendritic cell vaccine; Mucin antigen vaccine - MicroVAX

Latest Information Update: 30 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator MicroVAX
  • Developer MicroVAX; National Cancer Centre (Singapore)
  • Class Cancer vaccines; Dendritic cell vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Solid tumours

Most Recent Events

  • 28 Jul 2018 No recent reports of development identified for phase-I development in Solid-tumours in Singapore (Parenteral)
  • 28 Jul 2018 No recent reports of development identified for preclinical development in Solid-tumours in USA (Parenteral)
  • 04 Jun 2018 Safety and efficacy data from a phase I trial in Solid tumours presented at the 54th Annual Meeting of the American Society of Clinical Oncology (ASCO-2018)

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top